Utilization of antiepileptic drugs during pregnancy: Comparative patterns in 38 countries based on data from the EURAP registry

Grants

Funding Acknowledgements

EURAP has received financial support from Eisai, GlaxoSmithKline, Janssen-Cilag, Johnson & Johnson, Novartis, Pfizer, Sanofi-Aventis, and UCB Pharma. EURAP's national registries have received support from the same or other pharmaceutical companies and/or other institutions.